Codexis Logo - September 2023.png
Codexis to Present Update on ECO Synthesis™ Platform at TIDES Europe
October 26, 2023 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced a presentation highlighting the role of an enzymatic...
Codexis Logo - September 2023.png
Codexis to Report Third Quarter 2023 Financial Results on November 2
October 19, 2023 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the third...
Stephen Dilly Headshot
Codexis CEO Stephen Dilly Wins Prestigious 2023 Bloom Burton Award
September 29, 2023 07:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced President and Chief Executive Officer Stephen Dilly,...
Stephen Dilly Headshot
Codexis CEO Stephen Dilly Named as Finalist of 2023 Bloom Burton Award
September 18, 2023 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced Stephen Dilly, MBBS, PhD, President and Chief Executive...
CDXS Logo 2 April 2021.jpg
Codexis to Participate in Cantor Global Healthcare Conference
September 12, 2023 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will attend the Cantor Global Healthcare...
CDXS Logo 2 April 2021.jpg
Codexis Announces Agreement for Assignment and Assumption of San Carlos Facility Lease
September 07, 2023 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company has executed an Assignment and Assumption of...
CDXS Logo 2 April 2021.jpg
Codexis Reports Second Quarter 2023 Financial Results
August 03, 2023 16:05 ET | Codexis, Inc.
Company Recently Announced Enhanced Strategic Focus and Portfolio Prioritization Anticipate Demonstrating Gram-Scale Synthesis of ECO Synthesis™ Technology for RNAi Therapeutics...
CDXS Logo 2 April 2021.jpg
Codexis Documentary Showcases its Specialized Capabilities Engineering High Performance Enzymes to Enable Delivery of Novel Therapeutics
July 31, 2023 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., July 31, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the launch of a new mini documentary as part of an ongoing...
CDXS Logo 2 April 2021.jpg
Codexis Announces Enhanced Strategic Focus and Extends Projected Cash Runway to Mid-2026
July 20, 2023 16:05 ET | Codexis, Inc.
Organization Streamlined to Focus on Continued Advancement and Commercialization of ECO Synthesis™ Platform for RNAi Therapeutics Production Codexis Expects its Pharmaceutical Manufacturing Business...
CDXS Logo 2 April 2021.jpg
Codexis Announces New Employment Inducement Grants
June 09, 2023 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., June 09, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the approval of equity grants to four new employees as...